A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

7.3K views

⸱

DOI:

10.3791/58931

⸱

January 9th, 2019

 ,  ,  ,  ,  ,  , 

In This Article

Summary

Neurospheres grown as 3D cultures constitute a powerful tool to study glioma biology. Here we present a protocol to perform immunohistochemistry while maintaining the 3D structure of glioma neurospheres through paraffin embedding. This method enables the characterization of glioma neurosphere properties such as stemness and neural differentiation.

Abstract

Analysis of protein expression in glioma is relevant for several aspects in the study of its pathology. Numerous proteins have been described as biomarkers with applications in diagnosis, prognosis, classification, state of tumor progression, and cell differentiation state. These analyses of biomarkers are also useful to characterize tumor neurospheres (NS) generated from glioma patients and glioma models. Tumor NS provide a valuable in vitro model to assess different features of the tumor from which they are derived and can more accurately mirror glioma biology. Here we describe a detailed method to analyze biomarkers in tumor NS using immunohistochemistry (IHC) on paraffin-embedded tumor NS.

Introduction

Gliomas are primary solid tumors of the central nervous system classified by their phenotypic and genotypic characteristics according to the World Health Organization1. This classification incorporates the presence or absence of driver mutations, which represent an attractive source of biomarkers2. Biomarkers are biological characteristics that can be measured and evaluated to indicate normal and pathological processes, as well as pharmacological responses to a therapeutic intervention3. Biomarkers can be detected in tumor tissue and cells derived from glioma, enabling its biological characterizat....

Access restricted. Please log in or start a trial to view this content.

Protocol

All methods described here have been approved by the Institutional Animal Care and Use Committee (IACUC) of the University of Michigan.

1. Generation of Brain Tumor Neurospheres Derived from a Mouse Model

  1. Before the dissection procedure, prepare neural stem cell media (NSC Media: DMEM/F12 with 1x B27 supplement, 1x N2 supplement, 1x normocin, and 1x antibiotic/antimycotic supplemented with human recombinant EGF and basic-FGF at concentrations of 20 ng/mL each). Fill a 1.5 mL tube with 300 µL of NSC media and reserve for later.
  2. Select a mouse with a large tumor.
    NOTE: The size of a tumor can be monitored by ....

Access restricted. Please log in or start a trial to view this content.

Results

To monitor tumor development and evaluate if the tumor has reached the size necessary to generate NS, we analyzed the luminescence emitted by tumors using bioluminescence. This allows the study of transduction efficiency in the pups and tumor progression by the luminescence signal of luciferase (Figure 1A and 1B). When the tumor size reaches a signal of 1 x 107 photons/s/cm2/sr (Figure 1

Access restricted. Please log in or start a trial to view this content.

Discussion

In this article, we detail a versatile and reproducible method to perform immunohistochemistry on paraffin-embedded glioma NS, which maintain the characteristic 3D structure of tumor cells growing in the brain in situ. This technique possesses the following advantages over using cells plated onto glass or plastic surfaces: i) preservation of the 3D structure of NS; ii) avoiding of stress of cell dissociation before analysis of protein expression; iii) quenching of any endogenous fluorophore expression from genet.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

This work was supported by National Institutes of Health/National Institute of Neurological Disorders & Stroke (NIH/NINDS) Grants R37-NS094804, R01-NS074387, R21-NS091555 to M.G.C.; NIH/NINDS Grants R01-NS076991, R01-NS082311, and R01-NS096756 to P.R.L.; NIH/NINDS R01-EB022563; 1UO1CA224160; the Department of Neurosurgery; Leah's Happy Hearts to M.G.C. and P.R.L.; and RNA Biomedicine Grant F046166 to M.G.C. F.M.M. is supported by an F31 NIH/NINDS-F31NS103500. J.P. was supported by a Fulbright-Argentinian Ministry of Sports and Education Fellowship.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Coated microtome blade HP35Thermo Scientific3150734
Microtome RM 2135LeicaMR2135
Formalin solution, neutral buffered, 10%Sigma-aldrichHT501128-4L
Rabbit polyclonal anti-ATRX,Santa Cruz Biotechnologysc-15408IHC, 1:250 dilution
Rabbit polyclonal anti-Ki-67AbcamAb15580IHC, 1:1000 dilution
Rabbit polyclonal anti-OLIG2MilliporeAB9610IHC, 1:500 dilution
Goat polyclonal anti-rabbit biotin-conjugatedDakoE0432IHC, 1:1000 dilution
Vectastain Elite ABC HRP kitVector Laboratories IncPK-6100
BETAZOID DAB CHROMOGEN KITBiocare medicalBDB2004 L/price till 12/18
N-2 SupplementThermoFisher17502048
N-27 SupplementThermoFisherA3582801
Accutase® Cell Detachment SolutionBiolegend423201
AGAROSE LEGoldBioA-201-1000
Genesee Sc. CorporationOlympus 15 ml21-103
Genesee Sc. CorporationTC-75 treated Flask25-209
Genesee Sc. CorporationTC-25 treated Flask25-207
DMEM/F12Gibco11330-057NS media
HBSSGibcoTM14175-103balanced salt solution
C57BL/6TaconicB6-fC57BL/6 mouse

References

  1. Louis, D. N., et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropatholica. 131 (6), 803-820 (2016).
  2. Hochberg, F. H., et al.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Glioma BiomarkersParaffin EmbeddingTumor NeurospheresNeurosphere CultureATRX ExpressionKi67 ProliferationOLIG2 DifferentiationParaffin SectioningDAB Staining